NL194645C - Werkwijze voor het bereiden van 16alfa-hydroxy,17alfa-aminopregnaanderivaten. - Google Patents

Werkwijze voor het bereiden van 16alfa-hydroxy,17alfa-aminopregnaanderivaten. Download PDF

Info

Publication number
NL194645C
NL194645C NL8105201A NL8105201A NL194645C NL 194645 C NL194645 C NL 194645C NL 8105201 A NL8105201 A NL 8105201A NL 8105201 A NL8105201 A NL 8105201A NL 194645 C NL194645 C NL 194645C
Authority
NL
Netherlands
Prior art keywords
hydroxy
formula
hydrogen
mixture
derivatives
Prior art date
Application number
NL8105201A
Other languages
English (en)
Dutch (nl)
Other versions
NL194645B (nl
NL8105201A (nl
Original Assignee
Aventis Bulk S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Bulk S P A filed Critical Aventis Bulk S P A
Publication of NL8105201A publication Critical patent/NL8105201A/nl
Publication of NL194645B publication Critical patent/NL194645B/xx
Application granted granted Critical
Publication of NL194645C publication Critical patent/NL194645C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8105201A 1980-11-26 1981-11-17 Werkwijze voor het bereiden van 16alfa-hydroxy,17alfa-aminopregnaanderivaten. NL194645C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2622980 1980-11-26
IT26229/80A IT1134455B (it) 1980-11-26 1980-11-26 Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici

Publications (3)

Publication Number Publication Date
NL8105201A NL8105201A (nl) 1982-06-16
NL194645B NL194645B (nl) 2002-06-03
NL194645C true NL194645C (nl) 2002-10-04

Family

ID=11218998

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8105201A NL194645C (nl) 1980-11-26 1981-11-17 Werkwijze voor het bereiden van 16alfa-hydroxy,17alfa-aminopregnaanderivaten.

Country Status (16)

Country Link
US (1) US4412953A (de)
JP (3) JPS57118600A (de)
KR (1) KR870001903B1 (de)
AU (1) AU548998B2 (de)
BE (1) BE891242A (de)
CA (1) CA1176239A (de)
CH (1) CH657860A5 (de)
DE (1) DE3146785C2 (de)
FR (1) FR2494699A1 (de)
GB (1) GB2088382B (de)
HK (1) HK91086A (de)
IT (1) IT1134455B (de)
MY (1) MY8700182A (de)
NL (1) NL194645C (de)
NZ (1) NZ199056A (de)
SG (1) SG65486G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
AU2003278744B2 (en) * 2002-08-28 2010-07-29 Harbor Biosciences, Inc. Therapeutic treatment methods
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH444859A (de) * 1962-02-20 1967-10-15 Richter Gedeon Vegyeszet Verfahren zur Herstellung von neuen, im D-Ring basisch substituierten, 3-Keto-Steroiden
NL128816C (de) * 1965-04-22
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
GB1478968A (en) * 1973-07-11 1977-07-06 Akzo Nv Alkylated pregnanes
US4031075A (en) * 1973-07-11 1977-06-21 Akzona Incorporated Alkylated pregnanes and process for obtaining same

Also Published As

Publication number Publication date
DE3146785C2 (de) 1997-06-12
CH657860A5 (it) 1986-09-30
US4412953A (en) 1983-11-01
IT1134455B (it) 1986-08-13
FR2494699B1 (de) 1983-12-09
GB2088382B (en) 1984-12-12
CA1176239A (en) 1984-10-16
JPH0124159B2 (de) 1989-05-10
KR830007714A (ko) 1983-11-04
JPH01238598A (ja) 1989-09-22
HK91086A (en) 1986-12-05
GB2088382A (en) 1982-06-09
JPS57118600A (en) 1982-07-23
JPH01131194A (ja) 1989-05-24
KR870001903B1 (ko) 1987-10-21
BE891242A (fr) 1982-05-25
SG65486G (en) 1987-03-27
DE3146785A1 (de) 1982-07-01
NL194645B (nl) 2002-06-03
AU548998B2 (en) 1986-01-09
IT8026229A0 (it) 1980-11-26
AU7786381A (en) 1982-06-03
MY8700182A (en) 1987-12-31
NZ199056A (en) 1984-07-06
JPH0160479B2 (de) 1989-12-22
FR2494699A1 (fr) 1982-05-28
NL8105201A (nl) 1982-06-16

Similar Documents

Publication Publication Date Title
Krowicki et al. Synthesis of novel imidazole-containing DNA minor groove binding oligopeptides related to the antiviral antibiotic netropsin
JPH01104095A (ja) アンドロスタ−１，４−ジエン−３，１７−ジオンのメチレン誘導体の製造方法
US6201118B1 (en) Process for forming an N-acylated, N,N-containing bicyclic ring from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor
Sugimoto et al. Activation of dithiocarbamate by 2-halothiazolium salts
NL194645C (nl) Werkwijze voor het bereiden van 16alfa-hydroxy,17alfa-aminopregnaanderivaten.
US8183385B2 (en) SNAR process for preparing benzimidazole compounds
EP1075473B1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
US4634769A (en) Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
US20040138453A1 (en) Process for synthesizing bicyclic compounds from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor
SE421005B (sv) Triepoxiandrostanderivat till anvendning som utgangsmaterial for framstellning av kurareaktigt verkande steroidforeningar och forfarande for framstellning derav
US3117131A (en) Method for producing indoline-6-sulfonamides
RU2103275C1 (ru) Производные 17-галоген-4-азаандростена
US3136758A (en) Delta16-20-keto-pregnene derivatives and their preparation
HU191693B (en) Process for production of derivatives of 9-or-11 substituated apovincamin acid
EP0879242B1 (de) Verfahren zur herstellung von (11beta,16beta)-21-(3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
US3733329A (en) Process for the preparation of 2-and 3-aza-cholestane-derivatives
JPS5855459A (ja) 光学活性トリプトフアン誘導体の製造法
CA1087185A (en) Amino acids and derivatives thereof
EP3957641A1 (de) Verfahren zur herstellung von naldemedin
JPH01311084A (ja) ピロリジン誘導体及び製法
Radwan Synthesis and reactions of some new heterocyclic compounds containing thieno [2, 3-c] pyridazine moiety
JPS6183177A (ja) ５−メルカプト−１，２，３−チアジアゾ−ル塩の製法
HU210544B (en) 4-aza-androstene derivatives substituted with halogenatom in 17-position and process for their production
MUDGAL iWa^ ter of $ l) iIogopIip
JPH1053586A (ja) ９−ヒドロキシエリプチシンの製法

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: AVENTIS BULK S.P.A.